🇺🇸 FDA
Pipeline program

-

FESTA

Phase 2 small_molecule active

Quick answer

- for Primary or advanced breast cancer LumA or ER+ Lobular subtypes. is a Phase 2 program (small_molecule) at Vita (Europe) Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Vita (Europe) Limited
Indication
Primary or advanced breast cancer LumA or ER+ Lobular subtypes.
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials